Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.28% |
| 2 | Healthcare | 10.85% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
5451
Niu Technologies
NIU
$193M
| $235K | ﹤0.01% |
56,782
-12,800
| -18% | -$59.4K |
|
5452
RCM Technologies
RCMT
$208M
| $235K | ﹤0.01% |
20,316
+1,754
| +9% | +$23.1K |
|
5453
Precision Optics
POCI
$46.2M
| $234K | ﹤0.01% |
34,448
-666
| -2% | -$4.34K |
|
|
GDEV
5454
DELISTED
Nexters Inc. Ordinary Shares
GDEV
| $234K | ﹤0.01% |
34,461
+6,716
| +24% | +$45.6K |
|
5455
Union Bankshares
UNB
$109M
| $234K | ﹤0.01% |
10,575
-834
| -7% | -$20.7K |
|
5456
Humacyte
HUMA
$194M
| $234K | ﹤0.01% |
75,645
+26,586
| +54% | +$75.6K |
|
|
TWN
5457
Taiwan Fund
TWN
$527M
| $234K | ﹤0.01% |
8,670
+239
| +3% | +$6.25K |
|
|
TCRR
5458
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $233K | ﹤0.01% |
155,390
+108,995
| +235% | +$147K |
|
5459
ESS Tech
GWH
$18.9M
| $233K | ﹤0.01% |
11,175
-1,440
| -11% | -$40.1K |
|
|
PRDS
5460
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $232K | ﹤0.01% |
175,384
+155,272
| +772% | +$254K |
|
|
INSI
5461
DELISTED
Insight Select Income Fund
INSI
| $231K | ﹤0.01% |
14,522
+1,500
| +12% | +$23.7K |
|
5462
Stratus Properties
STRS
$154M
| $230K | ﹤0.01% |
11,505
+2,533
| +28% | +$52.7K |
|
5463
Mammoth Energy Services
TUSK
$163M
| $230K | ﹤0.01% |
54,506
+31,176
| +134% | +$186K |
|
|
RPC
5464
Ridgepost Capital
RPC
$991M
| $230K | ﹤0.01% |
22,740
-4,280
| -16% | -$46K |
|
5465
ProShares UltraShort Bloomberg Natural Gas
KOLD
$103M
| $230K | ﹤0.01% |
6,348
+2,440
| +62% | +$67.1K |
|
|
DXYN
5466
DELISTED
Dixie Group Inc
DXYN
| $230K | ﹤0.01% |
302,100
-20,001
| -6% | -$17.4K |
|
|
SGTX
5467
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $230K | ﹤0.01% |
18,987
+16,668
| +719% | +$173K |
|
|
SBDS
5468
DELISTED
Solo Brands Inc
SBDS
| $229K | ﹤0.01% |
798
+219
| +38% | +$42.1K |
|
5469
Tenaya Therapeutics
TNYA
$163M
| $229K | ﹤0.01% |
80,419
+52,559
| +189% | +$148K |
|
5470
John Marshall Bancorp
JMSB
$329M
| $229K | ﹤0.01% |
10,597
+4,345
| +69% | +$108K |
|
5471
CytomX Therapeutics
CTMX
$754M
| $229K | ﹤0.01% |
151,375
+133,426
| +743% | +$302K |
|
5472
MarketWise
MKTW
$56.6M
| $228K | ﹤0.01% |
6,163
-1,829
| -23% | -$73.5K |
|
|
CYT
5473
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $228K | ﹤0.01% |
125,203
+94,931
| +314% | +$154K |
|
|
BLRX
5474
BioLineRX
BLRX
$11.8M
| $228K | ﹤0.01% |
6,423
+99
| +2% | +$2.6K |
|
5475
FlexShares STOXX US ESG Select Index Fund
ESG
$137M
| $227K | ﹤0.01% |
2,290
-4,331
| -65% | -$418K |
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 163 new, 3,525 increased, 3,121 reduced and 300 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 163 new positions and closed 300 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.